Sponsor pipeline

VistaGen Therapeutics, Inc. clinical trial pipeline

Get alerts when VistaGen Therapeutics, Inc.'s trials change

3 active trials 1 recruiting 2 Phase 3 1 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

Active trials by phase

Phase 2
1
Phase 3
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT06615557 Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety… Social Anxiety Disorder (SAD) Active, Not Recruiting 2026-05-22
NCT06358651 Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety… Social Anxiety Disorder Active, Not Recruiting 2025-11-26
Phase 2
NCT06809179 A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of… Social Anxiety Disorder Recruiting 2026-02-05

Disease areas by active trials

Anxiety (3)

Get alerts when VistaGen Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free